Amodiaquine Hydrochloride Tablets
» Amodiaquine Hydrochloride Tablets contain an amount of amodiaquine hydrochloride (C20H22ClN3O·2HCl·2H2O) equivalent to not less than 93.0 percent and not more than 107.0 percent of the labeled amount of amodiaquine (C20H22ClN3O).
Packaging and storage— Preserve in tight containers.
Identification—
A: Infrared Absorption 197K—Prepare the test specimen as follows. Powder 1 or more Tablets, and transfer a portion of the powder, equivalent to about 50 mg of amodiaquine, to a 125-mL separator. Add 20 mL of water, and shake for 1 minute. Add 25 mL of chloroform and 1 mL of ammonium hydroxide, shake for 2 minutes, and when settled, filter the chloroform extract through cotton that previously has been rinsed with chloroform, collecting the extract in a vessel suitable for evaporation. Evaporate the chloroform, and dry the residue at 105 for 1 hour.
B: Ultraviolet Absorption 197U
Solution: prepared as directed in the Assay.
Dissolution 711
Medium: water; 900 mL.
Apparatus 2: 50 rpm.
Time: 30 minutes.
Procedure— Determine the amount of C20H22ClN3O·2HCl·2H2O dissolved from UV absorbances at the wavelength of maximum absorbance at about 342 nm on filtered portions of the solution under test, suitably diluted with water, if necessary, in comparison with a Standard solution having a known concentration of USP Amodiaquine Hydrochloride RS in the same medium.
Tolerances— An amount of amodiaquine hydrochloride (C20H22ClN3O·2HCl·2H2O) equivalent to not less than 75% (Q) of the labeled amount of amodiaquine (C20H22ClN3O) is dissolved in 30 minutes.
Uniformity of dosage units 905: meet the requirements.
Assay— Weigh and finely powder not fewer than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 300 mg of amodiaquine, to a 250-mL beaker, add about 100 mL of dilute hydrochloric acid (1 in 100), and heat on a steam bath for about 15 minutes with occasional stirring. Cool the mixture to room temperature, transfer to a 200-mL volumetric flask, add dilute hydrochloric acid (1 in 100) to volume, and mix. Pipet 10 mL of the clear supernatant into a 125-mL separator. Add about 10 mL of dilute hydrochloric acid (1 in 100), and wash with 20 mL of chloroform, discarding the washing. Add 4.5 mL of 1 N sodium hydroxide, and extract with four 25-mL portions of chloroform. Extract the combined chloroform solutions with three 50-mL portions of dilute hydrochloric acid (1 in 100). Combine the acid extracts in a 200-mL volumetric flask, add dilute hydrochloric acid (1 in 100) to volume, and mix. Pipet 20 mL of this solution into a 100-mL volumetric flask, add dilute hydrochloric acid (1 in 100) to volume, and mix. Concomitantly determine the absorbances of this solution and a solution of undried USP Amodiaquine Hydrochloride RS, in the same medium having a known concentration of about 15 µg per mL in 1-cm cells at the wavelength of maximum absorbance at about 342 nm, with a suitable spectrophotometer, using dilute hydrochloric acid (1 in 100) as the blank. Calculate the quantity, in mg, of C20H22ClN3O·2HCl·2H2O in the portion of Tablets taken by the formula:
21.68C(AU / AS)
in which C is the concentration, in µg per mL, calculated on the anhydrous basis, of the USP Amodiaquine Hydrochloride RS in the Standard solution; and AU and AS are the absorbances of the solution from the Tablets and the Standard solution, respectively. The quantity determined, multiplied by 0.7656, gives the equivalent quantity of C20H22ClN3O.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Behnam Davani, Ph.D., M.B.A.
Senior Scientist
1-301-816-8394
(MDAA05) Monograph Development-Antivirals and Antimicrobials
Reference Standards Lili Wang, Technical Services Scientist
1-301-816-8129
RSTech@usp.org
711 Margareth R.C. Marques, Ph.D.
Senior Scientist
1-301-816-8106
(BPC05) Biopharmaceutics05
USP32–NF27 Page 1538
Pharmacopeial Forum: Volume No. 34(3) Page 558
Chromatographic Column—
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.